29964212 26826604 30150329 28070747 32487421 29477412 34260979 25420446 34219518 33433875 32417789 26471212 26735510 30109474 31942705 27997281 30732430 26914914 30204664 27276999 31727215 - Search Results

Year	Number of Results
2015	3
2016	5
2017	2
2018	4
2019	2
2020	4
2021	3
2022	0

1

Dextromethorphan/Quinidine for Pseudobulbar Affect Following Stroke: Safety and Effectiveness in the PRISM II Trial.

Zorowitz RD, Alexander DN, Formella AE, Ledon F, Davis C, Siffert J. Zorowitz RD, et al. PM R. 2018 Jun 30:S1934-1482(18)30352-6. doi: 10.1016/j.pmrj.2018.06.003. Online ahead of print. PM R. 2018. PMID: 29964212

2

Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders.

Nguyen L, Thomas KL, Lucke-Wold BP, Cavendish JZ, Crowe MS, Matsumoto RR. Nguyen L, et al. Pharmacol Ther. 2016 Mar;159:1-22. doi: 10.1016/j.pharmthera.2016.01.016. Epub 2016 Jan 28. Pharmacol Ther. 2016. PMID: 26826604 Review.

3

Hypothalamic relapse of a cardiac large B-cell lymphoma presenting with memory loss, confabulation, alexia-agraphia, apathy, hypersomnia, appetite disturbances and diabetes insipidus.

Ospina-García N, Román GC, Pascual B, Schwartz MR, Preti HA. Ospina-García N, et al. BMJ Case Rep. 2018 Aug 27;2018:bcr2016217700. doi: 10.1136/bcr-2016-217700. BMJ Case Rep. 2018. PMID: 30150329 Free PMC article.

4

Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial.

Smith R, Pioro E, Myers K, Sirdofsky M, Goslin K, Meekins G, Yu H, Wymer J, Cudkowicz M, Macklin EA, Schoenfeld D, Pattee G. Smith R, et al. Neurotherapeutics. 2017 Jul;14(3):762-772. doi: 10.1007/s13311-016-0508-5. Neurotherapeutics. 2017. PMID: 28070747 Free PMC article. Clinical Trial.

5

Progressive supranuclear palsy: Advances in diagnosis and management.

Coughlin DG, Litvan I. Coughlin DG, et al. Parkinsonism Relat Disord. 2020 Apr;73:105-116. doi: 10.1016/j.parkreldis.2020.04.014. Epub 2020 May 25. Parkinsonism Relat Disord. 2020. PMID: 32487421 Free PMC article. Review.

6

Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study.

Hammond FM, Sauve W, Ledon F, Davis C, Formella AE. Hammond FM, et al. PM R. 2018 Oct;10(10):993-1003. doi: 10.1016/j.pmrj.2018.02.010. Epub 2018 Feb 23. PM R. 2018. PMID: 29477412 Free article. Clinical Trial.

7

Effect of one-year dextromethorphan/quinidine treatment on management of respiratory impairment in amyotrophic lateral sclerosis.

Sancho J, Ferrer S, Burés E, Luis Díaz J, Torrecilla T, Signes-Costa J, Servera E. Sancho J, et al. Respir Med. 2021 Sep;186:106536. doi: 10.1016/j.rmed.2021.106536. Epub 2021 Jul 7. Respir Med. 2021. PMID: 34260979

8

Dextromethorphan/quinidine: a review of its use in adults with pseudobulbar affect.

Yang LP, Deeks ED. Yang LP, et al. Drugs. 2015 Jan;75(1):83-90. doi: 10.1007/s40265-014-0328-z. Drugs. 2015. PMID: 25420446 Review.

9

Mood Disorders and Anxiety in Parkinson's Disease: Current Concepts.

Lintel H, Corpuz T, Paracha SU, Grossberg GT. Lintel H, et al. J Geriatr Psychiatry Neurol. 2021 Jul;34(4):280-288. doi: 10.1177/08919887211018267. J Geriatr Psychiatry Neurol. 2021. PMID: 34219518 Review.

10

Progressive Supranuclear Palsy and Corticobasal Degeneration.

Coughlin DG, Dickson DW, Josephs KA, Litvan I. Coughlin DG, et al. Adv Exp Med Biol. 2021;1281:151-176. doi: 10.1007/978-3-030-51140-1_11. Adv Exp Med Biol. 2021. PMID: 33433875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results